News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
FDA Approves Purdue Pharma L.P.'s New Opioid-Based Pain Medicine
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide "around-the-clock" relief to patients with moderate to severe pain.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
FDA
FDA’s latest rare disease framework seeks to prioritize consistency in flexibility
October 15, 2026
·
4 min read
·
Michael Gibney
Cancer
RevMed’s Rasonque gets a subtype data asterisk, but analysts remain bullish
October 12, 2026
·
3 min read
·
Michael Gibney
Gene editing
Reusing data could cut R&D costs and greatly increase gene editing’s reach: ARM
October 8, 2026
·
4 min read
·
Nick Paul Taylor
Drug Development
Newron reveals 5 deaths in late-stage schizophrenia program as FDA maintains hold
October 8, 2026
·
2 min read
·
Gabrielle Masson